Assyro AI

Orange Book product · Brand (NDA)

ILUVIEN

FLUOCINOLONE ACETONIDE

Brand (NDA)NDA 201923RX ALIMERA SCIENCES INC

At a glance

Sep 26, 2014

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Sep 26, 2014

    11 yr 11 mo ago

  2. Today

  3. Patent 8871241 expires

    Listed drug product patent expiration.

    Aug 12, 2027

    in 1 yr 2 mo

  4. Patent 9849027 expires

    Listed drug product patent expiration.

    Nov 07, 2028

    in 2 yr 5 mo

  5. Patent 9849027 expires

    Listed drug product patent expiration.

    Nov 07, 2028

    in 2 yr 5 mo

Pharmaceutical detail

Active ingredient

FLUOCINOLONE ACETONIDE

Strength

0.19MG

Dosage form

IMPLANT

Route

INTRAVITREAL

TE code

Not listed

Application

NDA 201923

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8871241Aug 12, 2027in 1 yr 2 mo
Product
9849027Nov 07, 2028in 2 yr 5 mo
ProductU-708
9849027Nov 07, 2028in 2 yr 5 mo
ProductU-4157
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.